logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global ...

By Intercept Pharmaceuticals, Inc. - Mar 09, 2023, 08:04 AM ET
Last Updated - Jun 22, 2023, 05:12 PM EDT
Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global ...

MORRISTOWN, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will be participating in investor meetings at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel on March 14, 2023. 

Meeting Details 
For investors attending the conference who wish to meet with the Intercept management team, please reach out to Nareg Sagherian at Intercept to check the team’s availability. 

About Intercept 
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit  www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.  

Contact 
For more information about Intercept, please contact: 

Investor inquiries:  investors@interceptpharma.com  
Media inquiries:  media@interceptpharma.com  


Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415